Skip to main content

Closed

GKOS: Glaukos Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+21.9% / yr

Operating margin-13.1%

ROIC-9.6%

Financially safe

Stretched

Debt / equity0.15×

Interest coverage-16.4×

Current ratio5.04×

Glaukos Corporation

GKOSNew York Stock Exchange·USD·Closed

Glaukos Corporation

GKOSNew York Stock Exchange·USD·Closed

$166.72

−1.07%

$166.72

−$1.80 (1.07%)

52W Range

84thpctl

Volume

0.80×avg

Mkt Cap

9.83BUSD

P/E

-51.3TTM

Div Yield

–ann

52W Range

84thpctl

Volume

0.80×avg

Market Cap

9.83BUSD

P/E Ratio

-51.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings